Author: pharmanewsdaily

Lowering Blood Pressure Naturally with Chaksu Seeds | Cassia Absus Benefits

pharmanewsdaily- April 11, 2021 0

Did you know that high BP management can be done without taking pills? Did you know that lowering blood pressures can be done through Chaksu ... Read More

FDA authorizes emergency use of Janssen COVID-19 Vaccine

pharmanewsdaily- February 28, 2021 0

The US Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for the Janssen COVID-19 Vaccine - Ad26.COV2.S manufactured by Johnson & ... Read More

Human tissue developer Humacyte to go public via $1.1bn merger with Alpha Healthcare

pharmanewsdaily- February 17, 2021 0

Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha Healthcare Acquisition Corp. (AHAC), in a deal that values the ... Read More

G1 Therapeutics gets Cosela FDA approval to reduce chemotherapy-induced bone marrow suppression

pharmanewsdaily- February 15, 2021 0

G1 Therapeutics has bagged approval for Cosela (trilaciclib) from the US Food and Drug Administration (FDA) for reducing bone marrow suppression caused by chemotherapy. Cosela ... Read More

Targovax gets FDA fast track status for ONCOS-102 in malignant pleural mesothelioma

pharmanewsdaily- February 15, 2021 0

Targovax, a Norwegian immune-oncology company, said that its lead candidate ONCOS-102 has secured the fast track designation from the US Food and Drug Administration (FDA) ... Read More

Sandoz to acquire GSK’s cephalosporin antibiotics business in $500m worth deal

pharmanewsdaily- February 13, 2021 0

Sandoz, a division of Swiss pharma giant Novartis, has agreed to acquire GSK’s cephalosporin antibiotics business in a deal worth up to $500 million. The ... Read More

AstraZeneca scores Chinese approval for heart failure therapy Forxiga

pharmanewsdaily- February 7, 2021 0

AstraZeneca said that Forxiga (dapagliflozin) has secured approval in China for its use in the reduction of the risk of cardiovascular (CV) death and hospitalization ... Read More

DJO acquires orthopedic implants provider Trilliant Surgical

pharmanewsdaily- February 6, 2021 0

DJO, a Texas-based medical technologies provider, has acquired Trilliant Surgical, an orthopedic foot and ankle implants provider, for an undisclosed price. The acquisition, which was ... Read More

Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India

pharmanewsdaily- February 5, 2021 0

US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus ... Read More

Thermo Fisher, JW Therapeutics sign CAR-T partnership in China

pharmanewsdaily- February 3, 2021 0

Thermo Fisher Scientific has signed an agreement with Chinese cell therapy company JW Therapeutics to provide the latter non-exclusive commercial access to its Gibco CTS ... Read More